The NLRP3 inflammasome may also inhibit CRC metastasis and proliferation by enhancing the IL-18-induced activity of NK cells independently of INF-γ, in addition to counteracting enterocolitis-associated intestinal carcinogenesis. This evidence concerns the gene NLRP3 and colorectal carcinoma.